MENU

CBAY CymaBay Therapeutics Forecast, Technical & Fundamental Analysis

CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developingÂ therapies for patients with liver and other chronic diseases with high unmet medical need... Show more

Industry: #Biotechnology

Get AI intraday signals

Interact to see
Advertisement

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

Interesting Tickers

1D

1W

1M

1Q

6M

1Y

5Y

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
TSLA	403.82	4.01	+1.00%
Tesla
GME	24.19	-0.04	-0.17%
GameStop Corp
SPY	752.10	-3.62	-0.48%
State Street SPDR S&P 500 ETF (SPY)
AAPL	338.32	-6.31	-1.83%
Apple
BTC.X	76677.300000	-1571.156200	-2.01%
Bitcoin cryptocurrency

Related Blogs

NTHI

NeOnc Technologies Holdings, Inc. (NTHI): Examining the Path to a $17 Price Target

GNLX

Genelux Corporation (GNLX): Analyst Targets Suggest +876% Upside Ahead of Phase 3 Readout

BDTX

BDTX vs NGEN: Contrasting Biotech Paths in Oncology and Neurorepair

INKT

MiNK Therapeutics (INKT) vs Pelthos Therapeutics (PTHS): Contrasting Paths in Early-Stage Biotech

RCKT

AUTL vs RCKT: Commercial Momentum in T-Cell Therapy Against Gene Therapy Catalysts

View all blogs related to
#Biotechnology

Interesting Articles

What are pink sheets?

Should I buy IPOs for my portfolio?

What should I look for in a good Investment Performance Evaluation calculator?

Best Homebuilding Stocks to Buy in 2024

Tickeron Unveils Day Trader, an Advanced AI Intraday Trading Agent

View all articles

A.I. Advisor

published General Information

General Information

a developer of therapeutics to treat metabolic diseases

Industry Biotechnology

Industry

Biotechnology

Address

7601 Dumbarton Circle

Phone

+1 510 293-8800

Employees

108

Web

https://www.cymabay.com